IceCure强调Prosense™冷冻消融技术在巴西的商业应用扩展,此前FDA已批准其用于乳腺癌治疗

美股速递
Jul 06

IceCure Medical Ltd. 强调,在获得美国食品药品监督管理局(FDA)针对乳腺癌治疗的批准后,其Prosense™冷冻消融系统在巴西的商业应用正在持续扩展。这一进展标志着该创新医疗技术在国际市场,特别是巴西这一重要医疗市场中的接受度和商业化进程正稳步提升。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10